Study Shows How Military Veterans Deal With Mesothelioma
A new study published in the European Journal of Oncology Nursing offers a comprehensive overview of how military veterans deal with a malignant mesothelioma diagnosis.
read more
New Jersey appeals court ruling could revive 1,000 talc lawsuits against Johnson & Johnson
A recent New Jersey appeals court ruling to revive two lawsuits that alleged talc in Johnson & Johnson Baby Powder causing ovarian cancer could...
read more
Jury Awards $750 Million in Damages Against Johnson & Johnson in Mesothelioma Lawsuit
On Thursday, February 6th, a New Jersey state court awarded plaintiffs $750 million in punitive damages to four people claiming they suffered due to...
read more
Jury Awards $25 million in Testicular Mesothelioma Lawsuit
A California jury held two construction companies and oil refineries accountable for the employee's testicular mesothelioma. The evidence presented...
read more
Study Shows How Military Veterans Deal With Mesothelioma
A new study published in the European Journal of Oncology Nursing offers a comprehensive overview of how military veterans deal with a malignant mesothelioma diagnosis.
read more
ONCOS-102 immunotherapy vaccine could benefit mesothelioma patient recovery
Amid the renewed public interest in vaccine development during the ongoing COVID-19 pandemic, little has been reported about developing a new...
read more
FDA approved phase I clinical trials of CAR T-cell therapy
The U.S Food and Drug Administration (FDA) has given a green signal to Atara Biotherapeutics to jump from preclinical studies to phase I clinical...
read more
Johnson & Johnson to pay out over $120 million in damages, per New York court
Johnson & Johnson was ordered by a New York state court to pay upward of $120 million in incurred damages to a Brooklyn husband and wife after...
read more
Asbestos found in talc-based cosmetics, per new study
A study commissioned by the Environmental Working Group (EWG) — a nonprofit advocacy organization working for corporate accountability and toxic...
read more
Targeting BCL-XL showed Impressive Development in Treating MPM
Inhibiting the expression of BCL-2 protein using BH3-mimetic drugs can disrupt the intrinsic apoptotic pathway in MPM (malignant pleural...
read more